Servando E Marron1, Lucia Tomas-Aragones2, Jorge Navarro-Lopez3, Uwe Gieler4, Jörg Kupfer5, Florence J Dalgard6, Lars Lien6, Andrew Y Finlay7, Françoise Poot8, Dennis Linder9, Jacek C Szepietowski10, Laurent Misery11, Gregor B E Jemec12, Dmitry Romanov13, Francesca Sampogna14, Csanad Szabo15, Ilknur K Altunay16, Saskia Spillekom-van Koulil17, Flora Balieva18, Faraz M Ali7, Jon A Halvorsen19, Pedro C Marijuan3. 1. Department of Dermatology, Royo Villanova Hospital, Aragon Health Sciences Institute (IACS), Zaragoza, Spain. 2. Department of Psychology, University of Zaragoza, Aragon Health Sciences Institute (IACS), Zaragoza, Spain. 3. Bioinformation Group, Aragon Health Sciences Institute (IACS), Zaragoza, Spain. 4. Department of Dermatology, Justus Liebig University, Giessen, Germany. 5. Institute of Medical Psychology, Justus Liebig University, Giessen, Germany. 6. Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway. 7. Department of Dermatology and Wound Healing, Cardiff University School of Medicine, Cardiff, UK. 8. Department of Dermatology, ULB Hospital ERASME, Brussels, Belgium. 9. Section of Biostatistics, University of Oslo, Oslo, Norway. 10. Department of Dermatology, Wroclaw Medical University, Wroclaw, Poland. 11. Department of Dermatology, University Hospital of Brest, Brest, France. 12. Department of Dermatology, Zealand University Hospital, Roskilde, Denmark. 13. Department of Psychiatry and Psychosomatics, I. M. Sechenov First Moscow State Medical University, Moscow, Russia. 14. Clinical Epidemiology Unit, Istituto Dermopatico dell'Immacolata, Rome, Italy. 15. Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary. 16. Department of Dermatology, Sisli Etfal Teaching and Research Hospital, Istanbul, Turkey. 17. Department of Medical Psychology, Radboud University Medical Centre, Nijmegen, The Netherlands. 18. Department of Dermatology, Stavanger University Hospital, Stavanger, Norway. 19. Department of Dermatology, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Abstract
BACKGROUND: The essential physical role, visibility and social importance of the hands place a major psychological burden on patients with hand eczema. OBJECTIVES: The aim of this study was to identify the psychological, social and clinical characteristics of patients with hand eczema, in particular the prevalences of depression, anxiety, suicidal ideation, and comorbidities. MATERIALS AND METHODS: Data on patients with hand eczema were analysed from a large European multicentre study conducted with dermatology outpatients from 13 countries. Groups of patients and controls were compared to analyse the psychological burden of hand eczema. RESULTS: Female patients with hand eczema had higher Hospital Anxiety and Depression Scale (HADS) scores for anxiety (n = 86, median = 7.0) than controls (n = 900, median = 5.0, P = .02), and for depression (median = 4.0) than controls (3.0, P < .001). Patients with high suicidal ideation, with low socioeconomic status and who were widowed or divorced were more likely to fulfil the HADS criteria for anxiety [odds ratio (OR) > 1, P = .038, P < .001, and P < .001, respectively]. The median Dermatology Life Quality Index score was 7.0 (n = 68). DISCUSSION: This study identifies a specific psychological burden experienced by hand eczema patients, highlighting the need for focused psychosocial interventions. Physicians in particular should be aware of the need to identify anxiety and depression in female patients.
BACKGROUND: The essential physical role, visibility and social importance of the hands place a major psychological burden on patients with hand eczema. OBJECTIVES: The aim of this study was to identify the psychological, social and clinical characteristics of patients with hand eczema, in particular the prevalences of depression, anxiety, suicidal ideation, and comorbidities. MATERIALS AND METHODS: Data on patients with hand eczema were analysed from a large European multicentre study conducted with dermatology outpatients from 13 countries. Groups of patients and controls were compared to analyse the psychological burden of hand eczema. RESULTS: Female patients with hand eczema had higher Hospital Anxiety and Depression Scale (HADS) scores for anxiety (n = 86, median = 7.0) than controls (n = 900, median = 5.0, P = .02), and for depression (median = 4.0) than controls (3.0, P < .001). Patients with high suicidal ideation, with low socioeconomic status and who were widowed or divorced were more likely to fulfil the HADS criteria for anxiety [odds ratio (OR) > 1, P = .038, P < .001, and P < .001, respectively]. The median Dermatology Life Quality Index score was 7.0 (n = 68). DISCUSSION: This study identifies a specific psychological burden experienced by hand eczemapatients, highlighting the need for focused psychosocial interventions. Physicians in particular should be aware of the need to identify anxiety and depression in female patients.
Authors: Manon M Sloot; Laura Loman; Geertruida L E Romeijn; Fieke M Rosenberg; Bernd W M Arents; Marie L A Schuttelaar Journal: Contact Dermatitis Date: 2022-01-06 Impact factor: 6.419
Authors: Laura Loman; Marjolein J Brands; Anna A L Massella Patsea; Klaziena Politiek; Bernd W M Arents; Marie L A Schuttelaar Journal: Contact Dermatitis Date: 2022-04-02 Impact factor: 6.419